These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 31514489

  • 1. Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis.
    Hoffman WH, Ishikawa T, Blum J, Tani N, Ikeda T, Artlett CM.
    J Clin Res Pediatr Endocrinol; 2020 Jun 03; 12(2):160-167. PubMed ID: 31514489
    [Abstract] [Full Text] [Related]

  • 2. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO, Dereke J, Hillman M.
    Lipids Health Dis; 2020 Oct 14; 19(1):223. PubMed ID: 33054750
    [Abstract] [Full Text] [Related]

  • 3. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
    Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K.
    Cardiovasc Diabetol; 2015 Sep 25; 14():126. PubMed ID: 26408307
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA, Kontogianni MD, Vlassopoulos A, Zhao S, Margariti A, Georgoulis M, Papatheodoridis G, Combet E.
    Metabolism; 2018 Jun 25; 83():120-127. PubMed ID: 29409822
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
    Bridglalsingh S, Archer-Hartmann S, Azadi P, Barbier de La Serre C, Remillard RL, Sunvold GD, Bartges JW.
    J Anim Physiol Anim Nutr (Berl); 2024 May 25; 108(3):735-751. PubMed ID: 38279966
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
    Xian N, Chen W, Zhang Y, Li J, Zhang N, Ye Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul 25; 50(7):493-9. PubMed ID: 26311638
    [Abstract] [Full Text] [Related]

  • 8. Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 iabetes Mellitus.
    Ninić A, Bojanin D, Sopić M, Mihajlović M, Munjas J, Milenković T, Stefanović A, Vekić J, Spasojević-Kalimanovska V.
    J Clin Res Pediatr Endocrinol; 2021 Feb 26; 13(1):61-71. PubMed ID: 32936764
    [Abstract] [Full Text] [Related]

  • 9. Advanced glycation end products are elevated in cystic fibrosis-related diabetes and correlate with worse lung function.
    Hunt WR, Helfman BR, McCarty NA, Hansen JM.
    J Cyst Fibros; 2016 Sep 26; 15(5):681-8. PubMed ID: 26817932
    [Abstract] [Full Text] [Related]

  • 10. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
    Kopytek M, Ząbczyk M, Mazur P, Undas A, Natorska J.
    Cardiovasc Diabetol; 2020 Jun 17; 19(1):92. PubMed ID: 32552684
    [Abstract] [Full Text] [Related]

  • 11. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
    Paradela-Dobarro B, Agra RM, Álvarez L, Varela-Román A, García-Acuña JM, González-Juanatey JR, Álvarez E, García-Seara FJ.
    Nutr Metab Cardiovasc Dis; 2019 Oct 17; 29(10):1050-1060. PubMed ID: 31371263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK, Wang Y, Shiu SW, Wong Y, Betteridge DJ, Tan KC.
    Diabet Med; 2013 Jun 17; 30(6):702-9. PubMed ID: 23432638
    [Abstract] [Full Text] [Related]

  • 14. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.
    Salonen KM, Ryhänen SJ, Forbes JM, Härkönen T, Ilonen J, Simell O, Veijola R, Groop PH, Knip M.
    Diabetes Metab Res Rev; 2017 May 17; 33(4):. PubMed ID: 27883367
    [Abstract] [Full Text] [Related]

  • 15. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
    Drinda S, Franke S, Schmidt S, Stoy K, Lehmann T, Wolf G, Neumann T.
    Complement Med Res; 2018 May 17; 25(3):167-172. PubMed ID: 29433120
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM, Barbalace MC, Cristani MT, Alibrandi A, Giovinazzo S, Giuffrida G, Trimarchi F, Cannavò S, Campennì A.
    J Endocrinol Invest; 2020 Sep 17; 43(9):1337-1342. PubMed ID: 32232775
    [Abstract] [Full Text] [Related]

  • 17. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
    Lemiesz M, Tenderenda-Banasiuk E, Sosnowska D, Rybi-Szumińska A, Storonowicz J, Lemiesz T, Wasilewska A.
    Curr Pharm Des; 2018 Sep 17; 24(27):3232-3239. PubMed ID: 30101695
    [Abstract] [Full Text] [Related]

  • 18. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
    Nowak A, Przywara-Chowaniec B, Damasiewicz-Bodzek A, Blachut D, Nowalany-Kozielska E, Tyrpień-Golder K.
    Cells; 2021 Dec 13; 10(12):. PubMed ID: 34944030
    [Abstract] [Full Text] [Related]

  • 19. Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.
    Santos-Bezerra DP, Machado-Lima A, Monteiro MB, Admoni SN, Perez RV, Machado CG, Shimizu MH, Cavaleiro AM, Thieme K, Queiroz MS, Machado UF, Giannella-Neto D, Passarelli M, Corrêa-Giannella ML.
    Diab Vasc Dis Res; 2018 Jan 13; 15(1):81-89. PubMed ID: 29027826
    [Abstract] [Full Text] [Related]

  • 20. Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy.
    Cabrera-García AI, Suchodolski JS, Steiner JM, Heilmann RM.
    J Vet Diagn Invest; 2020 Sep 13; 32(5):664-674. PubMed ID: 32715975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.